Product NDC: | 0904-6069 |
Proprietary Name: | Naproxen |
Non Proprietary Name: | Naproxen |
Active Ingredient(s): | 250 mg/1 & nbsp; Naproxen |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-6069 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075927 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090810 |
Package NDC: | 0904-6069-61 |
Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (0904-6069-61) |
NDC Code | 0904-6069-61 |
Proprietary Name | Naproxen |
Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (0904-6069-61) |
Product NDC | 0904-6069 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naproxen |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090810 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | NAPROXEN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |